BELLETTI, Daniela
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 7.631
EU - Europa 4.598
AS - Asia 1.145
SA - Sud America 25
AF - Africa 12
Continente sconosciuto - Info sul continente non disponibili 10
OC - Oceania 7
Totale 13.428
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 7.605
GB - Regno Unito 1.700
IT - Italia 1.504
CN - Cina 397
SE - Svezia 392
DE - Germania 264
TR - Turchia 249
HK - Hong Kong 228
UA - Ucraina 214
FR - Francia 123
FI - Finlandia 119
SG - Singapore 90
BG - Bulgaria 83
IN - India 59
KR - Corea 29
BE - Belgio 26
IR - Iran 26
IE - Irlanda 24
RU - Federazione Russa 24
RO - Romania 22
CA - Canada 21
NL - Olanda 18
CH - Svizzera 15
ES - Italia 12
ID - Indonesia 11
IL - Israele 11
GR - Grecia 10
LT - Lituania 10
PL - Polonia 10
VN - Vietnam 10
EU - Europa 9
JP - Giappone 8
PT - Portogallo 8
CO - Colombia 6
CZ - Repubblica Ceca 6
HU - Ungheria 6
IQ - Iraq 6
BR - Brasile 5
CL - Cile 5
BZ - Belize 4
NZ - Nuova Zelanda 4
PE - Perù 4
PK - Pakistan 4
TW - Taiwan 4
AU - Australia 3
EG - Egitto 3
MY - Malesia 3
SN - Senegal 3
YE - Yemen 3
AR - Argentina 2
BY - Bielorussia 2
DK - Danimarca 2
EC - Ecuador 2
NG - Nigeria 2
RS - Serbia 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AE - Emirati Arabi Uniti 1
AM - Armenia 1
AT - Austria 1
BO - Bolivia 1
DZ - Algeria 1
GH - Ghana 1
HR - Croazia 1
KH - Cambogia 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
LK - Sri Lanka 1
MA - Marocco 1
MX - Messico 1
PH - Filippine 1
ZA - Sudafrica 1
Totale 13.428
Salva come PNG Salva come JPEG
Città #
Southend 1.526
Fairfield 1.077
Woodbridge 706
Chandler 648
Ashburn 626
Jacksonville 454
Houston 445
Seattle 435
Wilmington 413
Dearborn 386
Ann Arbor 379
Cambridge 366
Nyköping 282
Modena 230
Hong Kong 227
Beijing 162
Izmir 157
Princeton 91
Milan 84
Chicago 82
San Diego 81
Sofia 81
Eugene 80
Redwood City 53
Rome 53
New York 52
Fremont 48
Falls Church 47
Helsinki 45
London 44
Singapore 39
Bologna 37
Bremen 34
Como 27
Napoli 26
Brussels 23
Des Moines 22
San Giuliano Milanese 22
Tulare 21
Dublin 19
Florence 19
Naples 18
Norwalk 16
Shanghai 16
Hefei 15
Kocaeli 15
Palermo 15
Boardman 13
Parma 13
Genoa 12
Perugia 12
Bari 11
Catania 11
Los Angeles 11
Phoenix 11
Frankfurt am Main 10
Guangzhou 10
Halifax 10
Kunming 10
Nanjing 10
Reggio Emilia 10
Turin 10
Bengaluru 9
Chennai 9
Pescara 9
Ferrara 8
Indiana 8
Jakarta 8
Mountain View 8
Saint Petersburg 8
Castelnuovo Di Porto 7
Dongguan 7
Gandhinagar 7
Hounslow 7
Jinan 7
Rende 7
Salerno 7
Dong Ket 6
Padova 6
Prescot 6
Saarbrücken 6
Venezia 6
Washington 6
Catanzaro 5
Changsha 5
Founex 5
Indianapolis 5
Kilburn 5
Lequile 5
Messina 5
Monza 5
Paris 5
Pavia 5
Santiago 5
Toronto 5
Wuhan 5
Auburn Hills 4
Baghdad 4
Belize City 4
Binyamina 4
Totale 10.141
Salva come PNG Salva come JPEG
Nome #
Nanovettori lipidici e polimerici per la somministrazione sito-specifica di farmaci antitumorali 363
AFM/TEM complementary structural analysis of surface-functionalized nanoparticles 329
NANOPARTICELLE IBRIDE PLGA/DOPE: STUDI DI TRANSFEZIONE, ESCAPE ENDOSOMIALE E TRAFFICKING CELLULARE 281
Novel Curcumin loaded nanoparticles engineered for Blood-Brain Barrier crossing and able to disrupt Abeta aggregates 279
PEG-g-chitosan nanoparticles functionalized with the monoclonal antibody OX26 for brain drug targeting 260
Protein corona and nanoparticles: How can we investigate on? 246
Protein cage nanostructure as drug delivery system: magnifying glass on apoferritin 244
AFM, ESEM, TEM and CLSM in liposomal characterization: a comparative study 238
Current Strategies for the Delivery of Therapeutic Proteins and Enzymes to Treat Brain Disorders 236
Nanoparticle transport across the blood brain barrier 230
Apoferritin nanocage as streptomycin drug reservoir: Technological optimization of a new drug delivery system 230
Targeted polymeric nanoparticles for brain delivery of high molecular weight molecules in lysosomal storage disorders 226
PEGylated siRNA lipoplexes for silencing of BLIMP-1 in Primary Effusion Lymphoma: In vitro evidences of antitumoral activity 226
NANOPARTICELLE POLIMERICHE PER LA VEICOLAZIONE DI MACROMOLECOLE PROTEICHE: STUDI PRELIMINARI DI CARATTERIZZAZIONE TECNOLOGICA 225
Endocytosis of Nanomedicines: The Case of Glycopeptide Engineered PLGA Nanoparticles 222
Application of Polymeric Nanoparticles for CNS Targeted Zinc Delivery In Vivo 221
Potential Use of Nanomedicine for Drug Delivery Across the Blood-Brain Barrier in Healthy and Diseased Brain 221
Qualitative and semiquantitative analysis of the protein coronas associated to different functionalized nanoparticles 216
Cidofovir-loaded liposomes: an intro-study using BCBL-1 cell line as a model for primary effusion lymphoma 207
Complessazione di SiRNA anti Blimp-1/PRDM con liposomi cationici: caratterizzazione chimico-fisica e validazione in vitro su cellule di PEL 207
Nanotechnology and Alzheimer’s disease: What has been done and what to do’ 203
The “fate” of polymeric and lipid nanoparticles for brain delivery and targeting: Strategies and mechanism of blood–brain barrier crossing and trafficking into the central nervous system 202
Cholesterol-loaded nanoparticles ameliorate synaptic and cognitive function in Huntington's disease mice 198
Exploiting Bacterial Pathways for BBB Crossing with PLGA Nanoparticles Modified with a Mutated Form of Diphtheria Toxin (CRM197): In Vivo Experiments 197
How does “Protein Corona” Affect the In vivo Efficiency of Polymeric Nanoparticles? State of Art 192
Reduced plaque size and inflammation in the APP23 mouse model for Alzheimer's disease after chronic application of polymeric nanoparticles for CNS targeted zinc delivery 191
Antineoplastic effects of liposomal siRNA treatment targeting BLIMP1/PRDM1 in primary effusion lymphoma 191
Anticancer drug-loaded quantum dots engineered polymeric nanoparticles: Diagnosis/therapy combined approach 190
AFM and TEM characterization of siRNAs lipoplexes: a combinatory tools to predict the efficacy of complexation 189
PLGA Nanoparticles Loaded Cerebrolysin: Studies on Their Preparation and Investigation of the Effect of Storage and Serum Stability with Reference to Traumatic Brain Injury 182
Apoferritin nanocage as drug reservoir: is it a reliable drug delivery system? 182
Nutlin-3 loaded nanocarriers: Preparation, characterization and in vitro antineoplastic effect against primary effusion lymphoma 182
Chemico-physical investigation of tenofovir loaded polymeric nanoparticles 181
Sialic Acid as a potential approach for the protection and targeting of nanocarriers 180
A Nanoparticle-based approach for drug delivery to the brain in Lysosomal Storage Disorders 180
Characterization of lysosome-destabilizing DOPE/PLGA nanoparticles designed for cytoplasmic drug release 179
EXPLOITING THE VERSATILITY OF CHOLESTEROL IN NANOPARTICLES FORMULATION 177
Functionalization of liposomes: microscopical methods for preformulative screening 176
Nanoparticles as Blood–Brain Barrier Permeable CNS Targeted Drug Delivery Systems 176
Insight on the fate of CNS-targeted nanoparticles. Part I: Rab5-dependent cell-specific uptake and distribution 171
Hybrid nanoparticles as a new technological approach to enhance the delivery of cholesterol into the brain 170
Novel polymeric/lipidic hybrid systems (PLHs) for effective Cidofovir delivery: preparation, characterization and comparative in vitro study with polymeric particles and liposomes 170
Nanomedicine in Alzheimer's disease: Amyloid beta targeting strategy 169
Biodegradable device applied in flatfoot surgery: Comparative studies between clinical and technological aspects of removed screws 166
Brain-targeted polymeric nanoparticles: in vivo evidences after different routes of administration in rodents. 161
LIPOPLEXES PER LA VEICOLAZIONE ED IL DIREZIONAMENTO DI siRNA AL PEL: VALUTAZIONE DELL’EFFICIENZA DI TRATTAMENTO CON SISTEMI LIPIDICI STABILIZZATI 158
Nanosistemi lipidici targettizzati per il direzionamento di siRNA con attività antineoplastica al linfoma primitivo delle cavità sierose (PEL) 158
Veicolazione liposomiale del cidofovir nel trattamento del PEL (Primary Effusion Lynphoma) 155
Nanomedicine: the future for advancing medicine and neuroscience 154
Poly (D,L-lactide-co-glycolide) nanoparticles loaded with Cerebrolysin display neuroprotective activity in a rat model of closed head injury 148
The bridge between Nanotechnology and Neuroscience: Neuro-Nanomedicine 148
NANOMEDICINE IN NEUROSCIENCE: THE POTENTIAL OF TARGETED NANOPARTICLES IN NEURODEGENERATIVE DISORDERS 148
NEUROTROPHIC FACTORS AND NEURODEGENERATIVE DISEASES: A DELIVERY ISSUE 140
NANOPARTICELLE DIREZIONANTI AL CERVELLO: RIPRISTINO DEI LIVELLI DI COLESTEROLO CELLULARE NELLA TERAPIA DELLA COREA DI HUNTINGTON. 139
Blood-Brain Barrier crossing of high molecular weight molecules mediated by nanoparticles: a potential approach to treat neurological Lysosomal Storage Disorders 136
TERAPIA NUTRIZIONALE PARENTERALE: APPROCCIO MULTIDISCIPLINARE, ORGANIZZATIVO E TECNOLOGICO 136
Immunoliposomal systems targeting the primary effusion lymphoma (PEL): in vitro study 135
Tumor-targeted immunoliposomal nanosystems to deliver either Cidofovir or Antineoplastic SiRNA against Primary Effusion Lymphoma (PEL) 131
Rab5-dependent cell-specific uptake and distribution of engineered nanoparticles for CNS targeted drug delivery in vivo 130
Nanomedicine in Neuroscience: the potential of targeted nanoparticles in crossing the Blood-Brain Barrier 129
Immunonanosystems to CNS pathologies: State of the art 128
Nano-Neuroscience: Targeted nanoparticles For CNS drug delivery 128
New perspectives in peptides- and antibodies- conjugated nanocarriers for brain delivery therapeutic purposes 128
siRNA-BASED THERAPEUTICS: DELIVERY AND TARGETING TO PEL TUMOR BY USING CATIONIC LIPOSOMES 125
Nanotechnology and Central Nervous System Drug Delivery 110
Leptin-conjugated nanoparticles as drug delivery system to the brain 109
KNOCK-DOWN DI BLIMP1/PRDM1 IN CELLULE PEL MEDIANTE siRNA; OTTIMIZZAZIONE DEL SISTEMA DI TRANSFEZIONE E STUDI IN VITRO 104
Cholesterol nanoparticles partially rescue the alterations in synaptic phenotype of the R6/2 mouse model of Huntington's Disease 103
Nanomedicine in Neuroscience: The potential of targeted nanoparticles in neurodegenerative disorders 103
Engineered nanoparticles for drug delivery to the CNS: in vivo experiments 101
Ligand- based strategies to modified NPs surface for blood-brain barrier crossing 94
Immunoliposome for the delivery of drugs and SiRNA for the treatment of cancer 91
Formulazione di siRNA anti blimp-1/PRDM in liposomi cationici: caratterizzazione chimico-fisica e validazione in vitro su cellule di LINFOMA EFFUSIVO PRIMARIO (pel) 91
Immunoliposomes to target the Primary Effusion Lymphoma (PEL): in vitro study 85
Immunoliposomes for the delivery of SiRNA and chemioterapeutic agent to primary effusion lymphoma 83
Formulation and characterization of new Polymeric/Lipidic Hybrid systems for cidofovir delivery 82
Immunoliposomes for the delivery of SiRNA and chemioterapeutic agent to primary effusion lymphoma 82
Development and characterization of immunoliposomes for Cidofovir and SiRNA delivery: a new strategy for the treatment of Primary Effusion Lymphoma 77
Nanotechnology in medicine: therapeutic strategies in neurological disorders 71
Corrigendum to: EXPLOITING THE VERSATILITY OF CHOLESTEROL IN NANOPARTICLES FORMULATION (International Journal of Pharmaceutics (2016) 511 (1) (331-340) (S0378517316306512) (10.1016/j.ijpharm.2016.07.022)) 71
Nanomedicine in neurodegenerative disorders: Understanding the journey 62
Totale 13.635
Salva come PNG Salva come JPEG
Categoria #
all - tutte 48.049
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 48.049
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20203.067 172 148 88 176 353 423 519 363 413 119 213 80
2020/20212.600 363 92 174 225 219 174 199 307 113 494 144 96
2021/20221.693 100 156 169 79 55 102 103 112 190 145 277 205
2022/20231.840 201 225 155 182 201 240 55 186 206 29 75 85
2023/20241.333 72 66 91 98 298 139 145 172 37 39 59 117
2024/2025163 163 0 0 0 0 0 0 0 0 0 0 0
Totale 13.635